Adaptive Biotechnologies Corp
ADPT· Nasdaq
Released Nov 12, 2019, after the close
10-Q filed Nov 12, 2019, 43 days after period end · 0001564590-19-042978
| Metric | Q3 2019 | Q3 2018 |
|---|---|---|
| Revenue | $26.06M | $17.19M |
| Net Income | -$13.95M | -$8.29M |
| EPS Diluted | -$0.11 | -$0.66 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Adaptive Biotechnologies Corp · CIK 1478320 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Sep 30, 2019 · filed Nov 12, 2019 · 43 d after period end
3.8% from the close of Nov 12, 2019 to the close of Nov 13, 2019, the first after the release.